In this issue:
ACR systemic lupus erythematosus treatment guideline
BSR guideline for prescribing csDMARDs
EULAR classification criteria for haemochromatosis arthropathy
EULAR disease activity score in antiphospholipid syndrome
Points to consider when assessing disease activity in Still’s disease
Quality improvement tips in rheumatology
Preventing infections in immunosuppressed patients
Pharmaceutical Benefits Advisory Committee (PBAC) recommendations
Revision concerns for the H3 Hintermann Ankle Replacement System
Intra-articular hyaluronic acid for osteoarthritis: is it effective?
The Federal Drug Administration relaxes approval requirement for common diseases
Canadian Rheumatology Association position statement on hydroxychloroquine monitoring
Bile acids, IgG autoantibodies and mental wellbeing in fibromyalgia
Conferences, workshops and CPD
Please login below to download this issue (PDF)